NNNN · Company research
Anbio Biotechnology Class A Ordinary Shares (NNNN): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 4.9 | $203,511,622.52 | 191610391.52 | 31.78149425084520672747 | — | — | 23.3339171656155703 | 6.6909165229288666 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.